ArticlePloS one2025
Prevalence of anxiety and depression symptoms and associated factors among women diagnosed with breast cancer: A cross-sectional study at Ocean Road Cancer Institute in Dar es Salaam-Tanzania.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Prevalence and Influencing Factors of Anxiety and Depression in Patients With Breast Cancer: A Meta-Analysis.Actas espanolas de psiquiatria · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionAnxiety and depression are the prevailing mental illnesses in low and middle-income nations. The shock of receiving breast cancer diagnosis and it's effects on daily life make it perplexing to adjust to the situation, hence anxiety and or depression symptoms develop. This study aimed to determine the prevalence and factors associated with anxiety and depression symptoms among women diagnosed with breast cancer at Ocean Road Cancer Institute (ORCI) in Dar es Salaam, Tanzania.
methodsWe conducted an analytical quantitative cross-sectional study between May and June 2023 among 384 women diagnosed with breast cancer using consecutive sampling. We used a pre-tested interviewer-administered questionnaire to collect data and the Statistical Package for Social Sciences (IBM SPSS) version 23 for data analysis. Bivariate and multivariate logistic regression analyses were performed to identify factors associated with anxiety and depression symptoms, and a p-value <0.05 was considered statistically significant.
resultsWe found a relatively high prevalence of anxiety (44.8%) and depression (50.5%). Participants who didn't know their stage of cancer [adjusted Odds Ratio (aOR): 0.39; 95% Confidence Interval (CI): 0.19, 0.83; p = 0.014]; in early stage of cancer [aOR: 0.36; 95%CI: 0.16, 0.81; p = 0.014]; with low state of hope [aOR: 0.52; 95%CI: 0.31, 0.86; p = 0.012]; and low cognitive reappraisal [aOR: 2.09; 95%CI: 1.33, 3.28; p < 0.001] were significantly associated with anxiety. Those without partners [aOR: 2.56; 95%CI: 1.59, 4.10; p < 0.001]; didn't know their stage of cancer [aOR: 0.38; 95%CI: 0.17, 0.86; p = 0.020]; receiving radiotherapy treatment [aOR: 3.86; 95% CI: 1.34, 11.08; p = 0.012]; and low cognitive reappraisal [aOR: 2.41; 95%CI: 1.52, 3.83; p < 0.001] were significantly associated with depression.
conclusionSymptoms of depression and anxiety were very common among women diagnosed with breast cancer in this study. We strongly advise for proper care including routine screening from mental health specialists to improve treatment outcomes among this population group.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.